Skip to main content
Top
Published in: Endocrine Pathology 3/2015

01-09-2015

Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas

Authors: Jian-Qiang Lu, Benjamin Adam, Andrew S. Jack, Anna Lam, Robert W. Broad, Constance L. Chik

Published in: Endocrine Pathology | Issue 3/2015

Login to get access

Abstract

Tumor immune microenvironment has been gradually recognized as a key contributor to tumor development, progression, and control. Immune cell infiltrates in brain tumors have been increasingly studied, but few have published on immune cell infiltrates in pituitary adenomas. We quantitatively assessed the infiltration of macrophages and lymphocytes in 35 pituitary adenomas, including 9 densely granulated growth hormone (DG-GH), 9 sparsely granulated growth hormone (SG-GH), 9 null cell (NC), and 8 adrenocorticotropic hormone (ACTH) adenomas. All the adenomas showed varying degrees of CD68+ macrophage infiltration. While SG-GH adenomas were significantly larger in size than DG-GH and ACTH adenomas, the infiltration of CD68+ macrophages was significantly greater in SG-GH than in DG-GH and ACTH adenomas. Similarly, NC adenomas that were significantly larger than DG-GH and ACTH adenomas had significantly greater infiltration of CD68+ macrophages than DG-GH and ACTH adenomas. The numbers of CD68+ macrophages were positively correlated with the tumor sizes and Knosp classification grades for tumor invasiveness. The infiltration of CD4+ and CD8+ T cells was relatively scant in these adenomas, but GH adenomas exhibited significantly more CD4+ and CD8+ T cells than non-GH adenomas. Both DG-GH and SG-GH adenomas had significantly more CD4+ cells than ACTH adenomas and significantly more CD8+ cells than NC adenomas. These results suggest an association of CD68+ macrophage infiltration with an increase in the pituitary adenoma size and invasiveness. Our observation contributes to understanding the growth environment of pituitary adenomas, for which adjuvant immunotherapy may help to constrain the tumor enlargement and invasiveness.
Literature
1.
go back to reference Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H (2012) The brain tumor microenvironment. Glia 60:502-514PubMedCrossRef Charles NA, Holland EC, Gilbertson R, Glass R, Kettenmann H (2012) The brain tumor microenvironment. Glia 60:502-514PubMedCrossRef
2.
4.
go back to reference Jack AS, Lu JQ (2015) Immune cell infiltrates in the Central Nervous System tumors. Austin J Neurosurg 2:1024 Jack AS, Lu JQ (2015) Immune cell infiltrates in the Central Nervous System tumors. Austin J Neurosurg 2:1024
5.
go back to reference Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51PubMedCrossRef Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39-51PubMedCrossRef
6.
go back to reference Komohara Y, Jinushi M, Takeya M (2014) Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 105:1-8PubMedCrossRef Komohara Y, Jinushi M, Takeya M (2014) Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 105:1-8PubMedCrossRef
7.
go back to reference Asgharzadeh S, Salo JA, Ji L et al (2012) Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J Clin Oncol 30:3525-3532PubMedCentralPubMedCrossRef Asgharzadeh S, Salo JA, Ji L et al (2012) Clinical significance of tumor-associated inflammatory cells in metastatic neuroblastoma. J Clin Oncol 30:3525-3532PubMedCentralPubMedCrossRef
8.
go back to reference Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA (2008) Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 15:1069-1074PubMedCentralPubMedCrossRef Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA (2008) Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 15:1069-1074PubMedCentralPubMedCrossRef
9.
go back to reference Wei IH, Harmon CM, Arcerito M, Cheng DF, Minter RM, Simeone DM (2014) Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors. Ann Surg 260:1088-1094PubMedCentralPubMedCrossRef Wei IH, Harmon CM, Arcerito M, Cheng DF, Minter RM, Simeone DM (2014) Tumor-associated macrophages are a useful biomarker to predict recurrence after surgical resection of nonfunctional pancreatic neuroendocrine tumors. Ann Surg 260:1088-1094PubMedCentralPubMedCrossRef
10.
go back to reference Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13:1472-1479PubMedCrossRef Forssell J, Oberg A, Henriksson ML, Stenling R, Jung A, Palmqvist R (2007) High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res 13:1472-1479PubMedCrossRef
11.
go back to reference Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A, Thompson TC (2000) Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 60:5857-5861PubMed Shimura S, Yang G, Ebara S, Wheeler TM, Frolov A, Thompson TC (2000) Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res 60:5857-5861PubMed
12.
go back to reference Wang B, Xu D, Yu X et al (2011) Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Ann Surg Oncol 18:2585-2593PubMedCrossRef Wang B, Xu D, Yu X et al (2011) Association of intra-tumoral infiltrating macrophages and regulatory T cells is an independent prognostic factor in gastric cancer after radical resection. Ann Surg Oncol 18:2585-2593PubMedCrossRef
13.
go back to reference Kayal S, Mathur S, Karak AK et al (2014) CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma. Leuk Lymphoma 55:1031-1037PubMedCrossRef Kayal S, Mathur S, Karak AK et al (2014) CD68 tumor-associated macrophage marker is not prognostic of clinical outcome in classical Hodgkin lymphoma. Leuk Lymphoma 55:1031-1037PubMedCrossRef
16.
go back to reference Ray D, Melmed S (1997) Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228PubMedCrossRef Ray D, Melmed S (1997) Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228PubMedCrossRef
17.
go back to reference Heshmati HM, Kujas M, Casanova S et al (1998) Prevalence of lymphocytic infiltrate in 1400 pituitary adenomas. Endocr J 45:357-361PubMedCrossRef Heshmati HM, Kujas M, Casanova S et al (1998) Prevalence of lymphocytic infiltrate in 1400 pituitary adenomas. Endocr J 45:357-361PubMedCrossRef
18.
go back to reference Rossi ML, Jones NR, Esiri MM, Havas L, Izzi MA, Coakham HB (1990) Mononuclear cell infiltrate and HLA-Dr expression in 28 pituitary adenomas. Tumori 76: 543-547PubMed Rossi ML, Jones NR, Esiri MM, Havas L, Izzi MA, Coakham HB (1990) Mononuclear cell infiltrate and HLA-Dr expression in 28 pituitary adenomas. Tumori 76: 543-547PubMed
19.
go back to reference Lupi I, Manetti L, Caturegli P et al (2010) Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma. J Clin Endocrinol Metab 95:289-296PubMedCentralPubMedCrossRef Lupi I, Manetti L, Caturegli P et al (2010) Tumor infiltrating lymphocytes but not serum pituitary antibodies are associated with poor clinical outcome after surgery in patients with pituitary adenoma. J Clin Endocrinol Metab 95:289-296PubMedCentralPubMedCrossRef
20.
go back to reference Gala RR (1991) Prolactin and growth hormone in the regulation of the immune system. Proc Soc Exp Biol Med 198:513-527PubMedCrossRef Gala RR (1991) Prolactin and growth hormone in the regulation of the immune system. Proc Soc Exp Biol Med 198:513-527PubMedCrossRef
21.
go back to reference Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER Jr (2011) Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg 114:336-344PubMedCrossRef Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER Jr (2011) Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg 114:336-344PubMedCrossRef
22.
go back to reference Mete O, Asa SL (2012) Clinicopathological correlations in pituitary adenomas. Brain Pathol 22:443-453PubMedCrossRef Mete O, Asa SL (2012) Clinicopathological correlations in pituitary adenomas. Brain Pathol 22:443-453PubMedCrossRef
23.
go back to reference Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610-617PubMedCrossRef Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610-617PubMedCrossRef
24.
go back to reference Asa SL, Digiovanni R, Jiang J et al (2007) A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors. Cancer Res 67:7505-7511PubMedCrossRef Asa SL, Digiovanni R, Jiang J et al (2007) A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumors. Cancer Res 67:7505-7511PubMedCrossRef
25.
go back to reference Obari A, Sano T, Ohyama K et al (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19:82-91PubMedCrossRef Obari A, Sano T, Ohyama K et al (2008) Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form. Endocr Pathol 19:82-91PubMedCrossRef
26.
go back to reference Yamada S, Aiba T, Sano T et al: Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology. Neurosurgery 33:20-27 Yamada S, Aiba T, Sano T et al: Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology. Neurosurgery 33:20-27
27.
28.
go back to reference Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555PubMedCrossRef Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549-555PubMedCrossRef
29.
go back to reference Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV (1986) Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65:733-744PubMedCrossRef Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV (1986) Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65:733-744PubMedCrossRef
30.
31.
go back to reference Kataki A, Scheid P, Piet M et al (2002) Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab Clin Med 140:320-328PubMedCrossRef Kataki A, Scheid P, Piet M et al (2002) Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab Clin Med 140:320-328PubMedCrossRef
32.
go back to reference Lamagna C, Aurrand-Lions M, Imhof BA (2006) Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol 80:705-713PubMedCrossRef Lamagna C, Aurrand-Lions M, Imhof BA (2006) Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol 80:705-713PubMedCrossRef
34.
go back to reference Dunn GP, Dunn IF, Curry WT (2007) Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun 7:12PubMedCentralPubMed Dunn GP, Dunn IF, Curry WT (2007) Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma. Cancer Immun 7:12PubMedCentralPubMed
35.
go back to reference Ohtani H (2007) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 7:4PubMedCentralPubMed Ohtani H (2007) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human colorectal cancer. Cancer Immun 7:4PubMedCentralPubMed
36.
go back to reference Sato E, Olson SH, Ahn J et al (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 102:18538-18543PubMedCentralPubMedCrossRef Sato E, Olson SH, Ahn J et al (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci U S A. 102:18538-18543PubMedCentralPubMedCrossRef
37.
go back to reference Lohr J, Ratliff T, Huppertz A et al (2011) Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β. Clin Cancer Res 17:4296-308PubMedCrossRef Lohr J, Ratliff T, Huppertz A et al (2011) Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β. Clin Cancer Res 17:4296-308PubMedCrossRef
38.
go back to reference Dunn GP, Fecci PE, Curry WT (2012) Cancer immunoediting in malignant glioma. Neurosurgery 71:201-222PubMedCrossRef Dunn GP, Fecci PE, Curry WT (2012) Cancer immunoediting in malignant glioma. Neurosurgery 71:201-222PubMedCrossRef
39.
go back to reference Nishioka H, Haraoka J (2005) Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas. Acta Neuropathol 109:598-602PubMedCrossRef Nishioka H, Haraoka J (2005) Significance of immunohistochemical expression of Rab3B and SNAP-25 in growth hormone-producing pituitary adenomas. Acta Neuropathol 109:598-602PubMedCrossRef
Metadata
Title
Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas
Authors
Jian-Qiang Lu
Benjamin Adam
Andrew S. Jack
Anna Lam
Robert W. Broad
Constance L. Chik
Publication date
01-09-2015
Publisher
Springer US
Published in
Endocrine Pathology / Issue 3/2015
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-015-9383-6

Other articles of this Issue 3/2015

Endocrine Pathology 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.